KHP Capital’s Gilead Sciences GILD Stock Holding History

KHP Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$185K	Hold	2,400	–	–	0.11%	70
2018 Q2	$170K	Hold	2,400	–	–	0.11%	67
2018 Q1	$181K	Buy	+2,400	New	+$191K	0.13%	63

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KHP Capital's GILD Position: Q3 2018 in Review

KHP Capital held its Gilead Sciences (GILD) position steady in Q3 2018 at 2,400 shares worth $185K. The position accounts for 0.11% of the portfolio, ranked #70.

KHP Capital first reported a position in GILD in Q1 2018 and has held it in 3 quarters since. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

KHP Capital held 2,400 shares of Gilead Sciences worth $185K as of Q3 2018.
KHP Capital left its Gilead Sciences share count unchanged in Q3 2018.
Gilead Sciences made up 0.11% of KHP Capital's portfolio in Q3 2018, its #70 holding.
KHP Capital first reported a position in Gilead Sciences in Q1 2018 and has held it in 3 quarters since.
1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.